Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi !

The PEARL trial: lasofoxifene and incidence of fractures, breast cancer and cardiovascular events in postmenopausal osteoporotic women (CROSBI ID 178700)

Prilog u časopisu | ostalo

Vukicevic, Slobodan ; Grgurevic, Lovorka The PEARL trial: lasofoxifene and incidence of fractures, breast cancer and cardiovascular events in postmenopausal osteoporotic women // International journal of clinical rheumatology, 6 (2011), 4; 387-391. doi: 10.2217/ijr.11.37

Podaci o odgovornosti

Vukicevic, Slobodan ; Grgurevic, Lovorka

engleski

The PEARL trial: lasofoxifene and incidence of fractures, breast cancer and cardiovascular events in postmenopausal osteoporotic women

Lasofoxifene is a selective estrogen-receptor modulator with high affinity and selectivity for estrogen receptors, leading to estrogen-agonist effects in some tissues and estrogen-antagonist effects in others. Postmenopausal Evaluation and Risk-Reduction with Lasofoxifene (PEARL) was a global, multicenter, double-blind, placebo-controlled randomized trial which recruited 8556 women between 59–80 years of age with osteoporosis under therapy with lasofoxifene 0.25 mg/d, lasofoxifene 0.5 mg/d, or placebo for 5 years. In postmenopausal women with osteoporosis, lasofoxifene 0.5 mg/day for 5 years reduced the risk of nonvertebral and vertebral fractures, major coronary heart disease, stroke and both total and estrogen receptor-positive invasive breast cancer risk. However, both doses of lasofoxifene increased the risk of venous thromboembolic events.

PEARL trial; osteoporosis; ER positive-breast cancer; heart disease; fracture

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

6 (4)

2011.

387-391

objavljeno

1758-4272

1758-4280

10.2217/ijr.11.37

Povezanost rada

nije evidentirano

Poveznice
Indeksiranost